ArticleJACC. Advances2026
Impact of a Postpartum Hypertension Clinic on Cardiovascular Screening After Hypertensive Disorder of Pregnancy.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Women's Cardiovascular Health: Progress, Gaps, and the Road Ahead.JACC. Advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostpartum hypertension (HTN) clinics may improve cardiovascular (CV) prevention care for individuals with hypertensive disorders of pregnancy (HDPs) at an increased risk of CV disease.
objectivesThis study compares rates of CV screening and engagement in postpartum care between postpartum HTN clinic attendees and nonattendees.
methodsWe compiled a retrospective cohort of patients with HDP who participated in remote blood pressure (BP) monitoring and remained hypertensive at 6 weeks postpartum. Our exposure was attending a postpartum HTN clinic within 1 year of delivery. We compared outcomes (1-year completion rates of outpatient BP ascertainment, lipid screening, hemoglobin A1c [HbA1c], and primary care physician [PCP] follow-up) using multivariate logistic regression adjusting for relevant demographic and clinical covariates.
resultsAmong 2,816 patients with HDP and persistent hypertension at 6 weeks postpartum, 7.6% (n = 213) had a clinic visit. Clinic attendees were more likely to be self-identified Black race (31.0% vs 20.9%; P = 0.004) and have chronic HTN (20.1% vs 13.3%; P = 0.008) or superimposed preeclampsia (5.5% vs 2.2%; P = 0.003). In adjusted analyses, for every 100 patients seen in clinic, there were 10.7 more BPs recorded (95% CI: 4.1-17.3), 26.8 more lipid panels (20.3-33.3), 22.5 more HbA1c screenings (16.4-28.7), and 10.8 more PCP follow-ups (3.9-17.6) for clinic attendees compared with non-attendees.
conclusionsAttendees at a postpartum HTN clinic had higher rates of CV risk factor screening, including lipid, HbA1c, and BP ascertainment, and PCP follow-up. These results demonstrate the importance of increasing access to postpartum HTN clinics to manage CV risk after HDP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.